Diabetes drug s new weight loss formula fuels cost-benefit debate
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
A diabetes drug for weight loss comes with a big price tag
latimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from latimes.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
BAGSVÆRD, Denmark, May 13, 2021 /PRNewswire/ Novo Nordisk today announced new results from the STEP phase 3a clinical trial programme, demonstrating potential benefits beyond weight loss for people with obesity being treated with semaglutide 2.4 mg. The trial showed that treatment with once-weekly semaglutide 2.4 mg led to significant improvements in physical functioning, such as climbing stairs and tying your shoes, and beneficial effects on weight related and health related quality of life scores (HRQoL) compared to placebo. Following the 68-week treatment period, more than half of participants had improved quality of life scores, indicating better physical function and improved psychological wellbeing.
‘Wonder’ jab that stops cravings could help you lose weight and fight obesity
13 May 2021, 10:14
Updated: 13 May 2021, 16:22
Invalid Date,
A WONDER jab that stops food cravings could soon help people lose weight.
People given the jab as part of a study rapidly dropped the pounds and ate less buffet food because their appetite was suppressed.
1
People given a weekly dose of semaglutide had a lower appetite and cravings for foodCredit: Alamy
If approved for use by medicine regulators, it could be a game-changer for people who can t fight the flab - and the obesity crisis.
More than 650 million people worldwide are obese, which can increase the risk for heartdisease, type 2 diabetes and more.